Bacille-Calmette-Guerin modulates human macrophage and dendritic cell response to SARS-CoV-2 S-glycoprotein
- PMID: 38073885
- PMCID: PMC10699688
- DOI: 10.1016/j.imj.2023.08.004
Bacille-Calmette-Guerin modulates human macrophage and dendritic cell response to SARS-CoV-2 S-glycoprotein
Abstract
Background: Given that epidemiological evidence suggests a potential protective role for Bacille-Calmette-Guerin against COVID-19, we aimed to explore whether pre-exposure of human monocyte-derived macrophages and dendritic cells to BCG could modulate their response to SARS-CoV-2 S-glycoprotein.
Methods: Dual THP-1 cells containing 2 reporter plasmids for transcription factors NF-κB, and IRF were differentiated into macrophages over 3 days using phorbol 12-myristate 13-acetate, or into dendritic cells over 6 days using commercial monocyte-dencritic cell differentiation media and matured with recombinant tumor necrosis factor-α. Cells were exposed to BCG for 24 h and then stimulated with SARS-CoV-2 S-glycoprotein for 24 hours.
Results: Pre-exposure of human macrophages and DCs to BCG increased IRF and NF-kb activation in response to the SARS-CoV-2 S-glycoprotein.
Conclusions: Our results showed that pre-exposure of both types of cells to BCG exhibited an increase in inflammatory transcription factors upon stimulation with S-glycoprotein. BCG-induced trained immunity may be an important tool for reducing susceptibility to SARS-CoV-2 infection and severity of COVID-19. Our findings help in the design of future BCG-based therapeutic approaches in the treatment of diseases caused by viral infections.
Keywords: BCG; Dendritic cell; Macrophage; SARS-CoV-2.
© 2023 The Author(s).
Figures


Similar articles
-
Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.Front Immunol. 2022 Feb 9;12:801799. doi: 10.3389/fimmu.2021.801799. eCollection 2021. Front Immunol. 2022. PMID: 35222355 Free PMC article.
-
Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection.Comput Biol Med. 2021 Nov;138:104891. doi: 10.1016/j.compbiomed.2021.104891. Epub 2021 Sep 29. Comput Biol Med. 2021. PMID: 34624759 Free PMC article.
-
Bacille Calmette-Guérin: An ophthalmic perspective.Surv Ophthalmol. 2022 Mar-Apr;67(2):307-320. doi: 10.1016/j.survophthal.2021.07.005. Epub 2021 Jul 31. Surv Ophthalmol. 2022. PMID: 34343536 Free PMC article. Review.
-
Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice.JCI Insight. 2022 Jun 8;7(11):e157393. doi: 10.1172/jci.insight.157393. JCI Insight. 2022. PMID: 35446790 Free PMC article.
-
Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19.Front Immunol. 2023 Jan 31;14:1118378. doi: 10.3389/fimmu.2023.1118378. eCollection 2023. Front Immunol. 2023. PMID: 36798128 Free PMC article. Review.
Cited by
-
The BCG vaccine and SARS-CoV-2: Could there be a beneficial relationship?Heliyon. 2024 Sep 19;10(18):e38085. doi: 10.1016/j.heliyon.2024.e38085. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39347386 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous